ClomMed 50 mg MediPharma

Description

ClomMed 50 mg MediPharma — clomiphene from MediPharma at 50 mg. SERM for PCT. Hypothalamic ER antagonism triggers GnRH → LH/FSH release, restoring testicular testosterone production.

Key Benefits

• SERM — primary PCT compound for LH/FSH recovery
• Stronger LH stimulation than tamoxifen
• Can be run solo for PCT or stacked with Nolvadex
• Mood / vision side-effects common at high doses
• Standard PCT 50 mg/day for 4 weeks, taper possible
• Each unit dosed at 50 mg — see Recommended Dosage below for protocol-specific intake

Quality Assurance

MediPharma is committed to delivering pharmaceutical-grade compounds with verified potency, purity, and sterility. Every batch undergoes rigorous third-party laboratory testing to ensure accurate dosing and absence of contaminants. With MediPharma, you receive a product backed by strict GMP manufacturing standards and complete traceability from raw material to finished product.

How It Works

Selective estrogen receptor modulator. Antagonises estrogen at the hypothalamus, which upregulates GnRH → LH → testicular testosterone output. Effective for restarting the HPTA after AAS-induced suppression.

Pharmacokinetics

Plasma half-life approximately 5 days. Once-daily dosing sufficient. Steady-state in 7–10 days.

Potential Side Effects

Mood effects (irritability, depression, emotional lability) in a subset of users — switch to Nolva if severe. Visual disturbances at high dose (blurring, aura) — reduce dose. Hot flashes and night sweats during initial titration.

Cycle & Stacking Guide

PCT workhorse. Standard: 50/50/25/25 mg/day over 4 weeks, starting 14 days post-last-long-ester injection. Often paired with Nolva 20 mg/day for dual SERM action.

Manufacturer Notes

MediPharma produces to a standard European formulary pattern. Vial specs and carrier details are printed on every label.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.